• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹部器官的多次移植]

[Multiple transplantation of abdominal organs].

作者信息

Starzl T

机构信息

Department of Surgery, Falk Clinic, Pittsburgh, PA 15213.

出版信息

Bull Acad Natl Med. 1991 Jun-Jul;175(6):835-47; discussion 847-8.

PMID:1742622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3002429/
Abstract

The transplantation of multiple abdominal viscera including liver-duodenum-pancreas, liver-stomach-duodenum-pancreas, and liver-intestine is being performed with increasing frequency and success. These procedures and other variations are derived from a seldom used multivisceral operation in which all of the foregoing organs are transplanted in bloc. It is described here how the full multivisceral transplantation and its less extensive derivatives are based on the same principles of procurement, preservation, and postoperative management. With all of these multiple organ permutations and with intestinal transplantation alone, management is complicated by inclusion in the grafts of a large lymphoreticular component which is capable of causing graft versus host disease (GVHD). Because of a systematic error in therapeutic philosophy, past efforts have been directed at altering or damaging the lymphoreticular cells by pretreatment of the donor or of the organs with drugs, irradiation or other means. From recent observations, the alternative approach is suggested of keeping these lymphoid depots intact which then become the site of 2 way cell traffic after transplantation. Under powerful immunosuppression such as that provided with FK 506, the donor lymphoreticular cells can circulate in the recipient without causing clinical GVHD, and the lymphoreticular cells in the graft become those of the recipient (local chimerism) without causing rejection. Even with avoidance of rejection and GVHD, metabolic interrelations between the grafted organs, and also between the graft organs and retained recipient viscera can affect the fate of the individual transplanted organs or retained recipient organs. The best delineated of these metabolic influences are mediated by the endogenous splanchnic hepatotrophic factors of which insulin has been the most completely studied. An understanding of these various immunologic and non-immunologic factors combined with the more potent immunosuppression which is now available is sure to stimulate efforts at transplantation of abdominal organs and particularly of the hollow viscera which heretofore have resisted such clinical efforts.

摘要

包括肝 - 十二指肠 - 胰腺、肝 - 胃 - 十二指肠 - 胰腺以及肝 - 肠在内的多种腹部脏器移植的开展频率和成功率都在不断提高。这些手术方式及其他变体均源自一种很少使用的多脏器手术,即上述所有器官整块移植。本文介绍了全多脏器移植及其范围较小的衍生手术是如何基于相同的获取、保存及术后管理原则进行的。在所有这些多器官组合以及单独进行肠道移植时,由于移植物中包含大量能够引发移植物抗宿主病(GVHD)的淋巴网状成分,管理变得复杂。由于治疗理念上的系统性错误,过去的努力一直致力于通过药物、辐射或其他手段对供体或器官进行预处理,以改变或损伤淋巴网状细胞。基于最近的观察结果,建议采用另一种方法,即保持这些淋巴组织库完整,使其在移植后成为双向细胞运输的场所。在诸如FK 506提供的强大免疫抑制作用下,供体淋巴网状细胞可以在受体中循环而不引发临床GVHD,移植物中的淋巴网状细胞会变成受体的细胞(局部嵌合)而不引发排斥反应。即使避免了排斥反应和GVHD,移植器官之间以及移植器官与保留的受体脏器之间的代谢相互关系仍可能影响单个移植器官或保留的受体器官的命运。这些代谢影响中最明确的是由内源性内脏肝细胞营养因子介导的,其中胰岛素是研究最为全面的。对这些各种免疫和非免疫因素的理解,再加上现有的更强效免疫抑制方法,必将推动腹部器官移植的努力,特别是对迄今为止一直抗拒此类临床尝试的中空脏器的移植。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/866df659f11e/nihms250002f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/3f849aa84b07/nihms250002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/564070bf50e2/nihms250002f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/32f1fb63a7dd/nihms250002f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/866df659f11e/nihms250002f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/3f849aa84b07/nihms250002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/564070bf50e2/nihms250002f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/32f1fb63a7dd/nihms250002f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa1/3002429/866df659f11e/nihms250002f4.jpg

相似文献

1
[Multiple transplantation of abdominal organs].[腹部器官的多次移植]
Bull Acad Natl Med. 1991 Jun-Jul;175(6):835-47; discussion 847-8.
2
The many faces of multivisceral transplantation.多脏器移植的诸多方面。
Surg Gynecol Obstet. 1991 May;172(5):335-44.
3
[Transplantation en masse of abdominal organs].[腹部器官的整块移植]
Ann Gastroenterol Hepatol (Paris). 1992 Jan-Feb;28(1):39-43.
4
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.联合器官与造血细胞移植后针对移植物抗宿主病和移植物排斥的保护性预处理。
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10.
5
Intestinal Transplantation: Include the Spleen with Intestinal Graft?肠移植:是否包括带肠移植物的脾脏?
Gastroenterol Clin North Am. 2024 Jun;53(2):281-288. doi: 10.1016/j.gtc.2023.12.002. Epub 2024 Mar 19.
6
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
7
Current status of graft-versus-host disease after intestinal transplantation.肠移植后移植物抗宿主病的现状。
Curr Opin Organ Transplant. 2019 Apr;24(2):199-206. doi: 10.1097/MOT.0000000000000624.
8
Multivisceral transplantation: where do we stand?多脏器移植:我们目前的状况如何?
Clin Liver Dis. 2014 Aug;18(3):661-74. doi: 10.1016/j.cld.2014.05.008.
9
Challenges with Intestine and Multivisceral Re-Transplantation: Importance of Timing of Re-Transplantation and Optimal Immunosuppression.肠道及多脏器再次移植的挑战:再次移植时机及优化免疫抑制的重要性
Ann Transplant. 2018 Feb 6;23:98-104. doi: 10.12659/aot.908052.
10
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.从Lewis大鼠到棕色挪威大鼠进行不同类型细胞和全器官移植后的可变嵌合现象、移植物抗宿主病和免疫耐受
Transplantation. 1995 Jul 27;60(2):158-71. doi: 10.1097/00007890-199507000-00009.

本文引用的文献

1
TRANSPLANTATION IN MASS OF THE KIDNEYS.肾脏整体移植。
J Exp Med. 1908 Jan 1;10(1):98-140. doi: 10.1084/jem.10.1.98.
2
Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow.犬肝同种移植中的重建问题,特别提及肝静脉血流在术后的作用。
Surg Gynecol Obstet. 1960 Dec;111:733-43.
3
[Some attempts at kidney transplantation in man].[人类肾脏移植的一些尝试]
Mem Acad Chir (Paris). 1951 Jul 4;77(22-24):755-64.
4
[Preliminary note on the study of renal functions of grafted kidneys in man].[关于人体移植肾肾功能研究的初步说明]
Bull Mem Soc Med Hop Paris. 1951;67(3-4):105-6.
5
[Graft of the kidney of an executed convict to a patient with congenital solitary kidney, with chronic hypertensive azotemic nephritis].
Bull Mem Soc Med Hop Paris. 1951;67(3-4):99-104.
6
Homologous human kidney transplantation. Experience with six patients.同种异体人肾移植。6例患者的经验。
Postgrad Med J. 1962 Sep;38(443):528-31. doi: 10.1136/pgmj.38.443.528.
7
[OPERATIVE TECHNIC OF VASCULAR ANASTOMOSES AND VISCERAL TRANSPLANTATION].[血管吻合术与内脏移植的手术技术]
Lyon Med. 1964 Dec 20;212:1561-8.
8
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.人类肝脏同种移植
Surg Gynecol Obstet. 1963 Dec;117:659-76.
9
Renal homotransplantation in man after radiation of the recipient. Experience with six patients since 1959.受体接受辐射后进行的人体肾同种移植。1959年以来6例患者的经验。
Am J Med. 1962 Jun;32:854-71. doi: 10.1016/0002-9343(62)90032-3.
10
[An attempted kidney transplantation in man: medical and biological aspects].
Presse Med (1893). 1953 Nov 4;61(70):1419-23.